View Filing Data

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
Sep. 30, 2009	Dec. 31, 2009	Dec. 31, 2008
ASSETS
Cash and cash equivalents	$ 22,577		$ 30,945
Restricted cash	2,350		1,864
Accounts receivable, net of allowance of $16 and $23 in 2009 and 2008, respectively	287		291
Income tax receivable	3,025		3,531
Inventories, net	29,427		31,313
Prepaid expenses and other current assets	3,724		3,946
Deferred income tax assets	4,866		5,632
Total current assets	66,256		77,522
Property and equipment, net	29,547		36,202
Construction in progress	630		840
Long-term restricted cash	7,075		7,579
Other assets	2,516		1,456
Long-term deferred income tax assets	516		459
Total assets	106,540		124,058
LIABILITIES AND SHAREHOLDERS' EQUITY
Current portion of capital leases	843		131
Accounts payable	6,695		5,067
Accrued expenses	21,904		24,324
Commissions and incentives payable	14,030		11,453
Taxes payable	1,699		873
Current deferred tax liability	225		192
Deferred revenue	3,892		3,476
Total current liabilities	49,288		45,516
Capital leases, excluding current portion	1,272		155
Long-term deferred income tax liabilities	3,616		6,075
Other long-term liabilities	3,446		3,583
Total liabilities	$ 57,622		55,329
Commitments and contingencies
Shareholders' equity
Preferred stock, $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding	$ 0		0
Common stock, $0.0001 par value, 99,000,000 shares authorized, 27,687,882 shares issued and 26,480,788 shares outstanding in 2009, and 27,667,882 shares issued and 26,460,788 shares outstanding in 2008.	3		3
Additional paid-in capital	41,243		40,753
Retained earnings	23,593		44,170
Accumulated other comprehensive loss	(1,130)		(1,406)
Less treasury stock, at cost, 1,207,094 shares in 2009 and 2008	(14,791)		(14,791)
Total shareholders' equity	48,918		68,729
Total liabilities and shareholders' equity	$ 106,540		$ 124,058

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2009
Notes To Financial Statements [Abstract]
Organization And Summary Of Significant Accounting Policies	div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"NOTE 1: ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Mannatech, Incorporated (together with its subsidiaries, the #8220;Company#8221;), located in Coppell, Texas, was incorporated in the state of Texas on November 4, 1993 and is listed on the NASDAQ Global Select Market under the symbol #8220;MTEX#8221;. The Company develops, markets, and sells high-quality, proprieta ry nutritional supplements, topical and skin care products, and weight-management products that are primarily sold to independent associates and members located in the United States, Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, South Africa, Singapore, Austria, the Netherlands, Norway, and Sweden./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Independent associates (#8220;associates#8221;) purchase the Company#8217;s products at published wholesale prices to either sell to retail customers or consume personally. Members purchase the Company#8217;s products at a discount from published retail prices primarily for personal consumption. The Company cannot distinguish pers onal consumption sales from other sales because it has no involvement in its products after delivery, other than customary product warranties and returns. Only independent associates are eligible to earn commissions and incentives./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the Company#8217;s consolidated financial statements and footnotes contained herein do not include all of the information and footnotes required by accounting principles generally accepte d in the United States of America (#8220;GAAP#8221;) to be considered #8220;complete financial statements#8221;. However, in the opinion of the Company#8217;s management, the accompanying unaudited consolidated financial statements and footnotes contain all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company#8217;s consolidated financial information as of, and for, the periods presented. The Company cautions that its consolidated results of operations for an interim period are not necessarily indicative of its consolidated results of operations to be expected for its fiscal year. The December 31, 2008 consolidated balance sheet was included in the audited consolidated financial statements in the Company#8217;s annual report on Form 10-K for the year ended December 31, 2008 and filed with the United States Securities and Exchange Commission on March 12, 2009 (#8220;2008 Annual Report#8221;), w hich includes all disclosures required by GAAP. Therefore, these unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company included in the 2008 Annual Report./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Principles of Consolidation/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The consolidated financial statements and footnotes include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Use of Estimates/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The preparation of the Company#8217;s consolidated financial statements in accordance with GAAP requires the use of e stimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company#8217;s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. Actual results may differ from these estimates under different assumptions or conditions./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and esti mates considered to be the most significant are described in this note to the consolidated financial statements,#160;font style="DISPLAY: inline; FONT-STYLE: italic"Organization and Summary of Significant Accounting Policies/font./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Cash and Cash Equivalents/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company includes in its cash and cash equivalents credit card receivables due from its credit card processor, as the cash proceeds from credit card receivables are generally received within 24 to 72 hours. As of September 30, 2009 and December 31, 2008, credit card receivables were $3.8 million and $3.3 million, respectively. Additionally, as of September 30, 2009 and December 31, 2008, cash and cash equivalents held in bank accounts in foreign countries totaled $11.8 million and $18.2 million, respectively./font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Restricted Cash/font/font/div div style="DIS PLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company is required to restrict cash for (i) direct selling insurance premiums and credit card sales in the Republic of Korea, (ii) reserve on credit card sales in North America, and (iii) Australia building lease collateral. As of September 30, 2009 and December 31, 2008, our total restricted cash was $9.4 million./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Accounts Receivable/font/font gt;/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Accounts receivable are carried at their estimated collectible amounts. Receivables are created upon shipment of an order if the credit card payment is rejected or does not match the order total. As of September 30, 2009 and December 31, 2008, receivables consisted primarily of amounts due from members and associates. The Company periodically evaluates its receivables for collectability based on historical experience, recent account activities, and the length of time receivables are past due, and writes-off receivables when they become uncollectible. At September 30, 2009 and December 31, 2008, the Company held an allowance for doubtful accounts of less than $0.1 million./font/div div sty le="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Inventories/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Inventories consist of raw materials, work in progress, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or market. The Company periodically reviews inventories for obsolescence and any inventories identified as obsolete are reserved or written off. /font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Other Assets/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"As of September 30, 2009 and December 31, 2008, other assets of $2.5 million and $1.5 million primarily consisted of deposits for contracts and building leases in various locations./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Commissions and Incentives/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Independent associates earn commissions and incentives based on their direct and indirect commissionable net sales over 13 business periods. Each business period equals 28 days. The Company accrues commissions and incentives when earned by independent associates and pays commissions on product sales three weeks following the business period end and pays commissions on its pack sal es five weeks following the business period end./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Other Long-Term Liabilities/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"In August 2003, the Company entered into a Long-Term Post-Employment Royalty Agreement with Dr.#160;Bill#160;McAnalley, the Company#8217;s former Chief Science Officer, pursuant to which the Company is required to pay Dr.#160;McAnalley, or his heirs, royalties for ten years beginning September 2005 through August 2015. Quarterly payments related to this Long-Term Post-Employment Royalty Agreement are based on certain applicable annual global product sales by the Company in excess of $105.4 million. At the time the Company entered into this Long-Term Post-Employment Royalty Agreement, it was considered a post-employment benefit and the Company was required to measure and accrue the present value of the estimated future royalty payments related to the post-employment royalty benefit and recognize it over the life of Dr.#160;McAnalley#8217;s employment agreement, which was two years. As of September 30, 2009, the Company#8217;s liability related to this royalty agreement was $2.1 million, of which $0.3 million was currently due and included in accrued expenses.#160;#160;As of December#160;31, 2008, the Company#8217;s long-term liability related to this royalty agreem ent was $2.4 million, of which $0.4 million was currently due and included in accrued expenses./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Certain operating leases for the Company#8217;s regional office facilities contain a restoration clause that requires the Company to restore the premises to its original condition. As of September 30, 2009 and December 31, 2008, accrued restoration costs related to these leases amounted to $0.4 million. At September 30, 2009 and December 31, 2008, the Company also recorded a long-term liability for an estimated deferred benefit obligation related to a deferred benefit plan for its Japan operations of $0.8 million./font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; FONT-SIZE: 10pt; TEXT-DECORATION: underline"Comprehensive Income (loss) and Accumulated Other Comprehensive Income (Loss/fontfont style="DISPLAY: inline; TEXT-DECORATION: underline")/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from nonowner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners . The Company#8217;s comprehensive income (loss) consists of the Company#8217;s net income (loss), foreign currency translation adjustments from its Japan, Republic of Korea, Taiwan, Norway, and Sweden operations, and changes in the pension obligation for its Japanese employees./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Revenue Recognition/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Rom an"The Company#8217;s revenue is derived from sales of its products, sales of its starter and renewal packs, and shipping fees. Substantially all of the Company#8217;s products are sold to independent associates at published wholesale prices and to members at discounted published retail prices. The Company recognizes revenue upon receipt of packs and products by its customers. The Company records revenue net of any sales taxes and records a reserve for expected sales returns based on its historical experience./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company defers certain components of its revenue. Total deferred revenue consists of revenue received from: (i) sales of packs and products, which were shipped but not received by customers by period end; (ii) one-year magazine subscriptions; (iii) pack sales when the pack sale price exceeds the wholesale value of all individual components within the pack; and (iv) prepaid registration fees from customers planning to attend a future corporate-sponsored event. The Company recognizes deferred revenue from shipped packs and products upon receipt by the customer. Corporate-sponsored event revenue is recognized when the event is held. All other deferred revenue is recognized ratably over one year. Components of deferred revenue were as follows:/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div align="left" table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"September 30, 2009/font/div /td td nowrap="nowrap" valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"December#160;31,#160;2008/font/div /td td nowrap="nowrap" valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td valign="bottom" bgcolor="#ffffff"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td valign="bottom" gt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"#160;/font/td td colspan="6" valign="bottom" bgcolor="#ffffff" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"(in thousands)/font/div /td td nowrap="nowrap" valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left" t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Revenue related to undelivered packs and products/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3,779/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DIS PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3,228/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Revenue related to a one-year magazine subscription and pack sales/font/div div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"exceeding the wholesale value of individual components sold/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"93/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left" lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"133/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px" t; div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Revenue related to future corporate-sponsored events/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"20/font/td td nowrap="nowrap" valign="bottom" width="1%" sty le="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"115/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td /trtr bgcolor="white" td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total deferred revenue/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" gt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3,892/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3,476/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /tr/table /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"We estimate a sales return reserve for expected sales refunds based on our historical experience over a rolling six month period. If actual results differ from our estimated sales returns reserves due to various factors, the amount of revenue recorded each period could be materially affected. Historically, our sales returns have not materially changed through the years as th e majority of our customers return their merchandise within the first 90 days after the original sale. Sales returns have averaged 1.5% or less of our gross sales. As of September 30, 2009 our sales return reserve was composed of the following (in thousands):/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div align="left" table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style ="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"September 30, 2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="88%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Sales reserve as of January 1, 2009/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"719/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="88%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font st yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Provision related to sales made in current period/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2,475/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="88%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Provision related to sales made in prior periods/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"106/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="88%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Actual returns or credits related to current period/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" ;(1,886 /font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Actual returns or credits related to prior periods/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inlin e; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(808 /font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Sales reserve as of September 30, 2009/font/div /td td align="right" valign="bottom" width="1%" sty le="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"606/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /tr/table /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MA RGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Shipping and Handling Costs/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company records freight and shipping fees collected from its customers as revenue. The Company records inbound freight as cost of sales and records shipping and handling costs associated with shipping products to customers as selling and administrative expenses. Total shipping and handling costs included in selling and administrative expenses were approximately $3.6 million and $3.4 million for the three months ended September 30, 2009 and 2008, re spectively, and $10.6 and $11.2 million for the nine months ended September 30, 2009 and 2008, respectively./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Reclassifications/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Certain reclassifications have been made to the financial statements for prior periods to conform to the current period presentation./font/div div styl e="DISPLAY: block; TEXT-INDENT: 0pt"br //div /div
Organization	div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Mannatech, Incorporated (together with its subsidiaries, the #8220;Company#8221;), located in Coppell, Texas, was incorporated in the state of Texas on November 4, 1993 and is listed on the NASDAQ Global Select Market under the symbol #8220;MTEX#8221;. The Company develops, markets, and sells high-quality, proprietary nutritional supplements, topical and skin care products, and weight-management products that are primarily sold to independent associates and members located in the United States, Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, Germany, South Africa, Singapore, Austria, the Netherlands, Norway, and Sweden. /font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Independent associates (#8220;associates#8221;) purchase the Company#8217;s products at published wholesale prices to either sell to retail customers or consume personally. Members purchase the Company#8217;s products at a discount from published retail prices primarily for personal consumption. The Company cannot distinguish personal consumption sales from other sales because it has no involvement in its products after delivery, other than customary product warranties and returns. Only independent associates are eligible to earn commissions and incentives./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="D ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with instructions for Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, the Company#8217;s consolidated financial statements and footnotes contained herein do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America (#8220;GAAP#8221;) to be considered #8220;complete financial statements#8221;. However, in the opinion of the Company#8217;s management, the accompanying unaudited consolidated financial statements and footnotes contain all adjustments, including normal recurring adjustments, considered necessary for a fair presentation of the Company#8217;s consolidated financial information as of, and for, the periods presented. The Company cautions that its consolidated results of operations for an interim period are not necessarily indicative of its consolidated results of operations to be expected for its fiscal year. The December 31, 2008 consolidated balance sheet was included in the audited consolidated financial statements in the Company#8217;s annual report on Form 10-K for the year ended December 31, 2008 and filed with the United States Securities and Exchange Commission on March 12, 2009 (#8220;2008 Annual Report#8221;), which includes all disclosures required by GAAP. Therefore, these unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company included in the 2008 Annual Report./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div /div
Summary of Significant Accounting Policies	div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Principles of Consolidation/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The consolidated financial statements and footnotes include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br / t;/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Use of Estimates/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The preparation of the Company#8217;s consolidated financial statements in accordance with GAAP requires the use of estimates that affect the reported value of assets, liabilities, revenues and expenses. These estimates are based on historical experience and various other factors. The Company continually evaluates the information used to make these estimates as the business and economic environment changes. Historically, actual results have not varied materially from the Company#8217;s estimates and the Company does not currently anticipate a significant change in its assumptions related to these estimates. Actual results may differ from these estimates under different assumptions or conditions./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The use of estimates is pervasive throughout the consolidated financial statements, but the accounting policies and estimates considered to be the most significant are described in this note to the consolidated financial statements,#160;font style="DISPLAY: inline; FONT-STYLE: italic"Organization and Summary of Significant Accounting Policies/font./font gt;/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Cash and Cash Equivalents/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. The Company includes in its cash and cash equivalents credit card receivables due from its credit card processor, as the cash proceeds from credit card receivabl es are generally received within 24 to 72 hours. As of September 30, 2009 and December 31, 2008, credit card receivables were $3.8 million and $3.3 million, respectively. Additionally, as of September 30, 2009 and December 31, 2008, cash and cash equivalents held in bank accounts in foreign countries totaled $11.8 million and $18.2 million, respectively./font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Restricted Cash/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company is required to restrict cash for (i) direct selling insurance premiums and credit card sales in the Republic of Korea, (ii) reserve on credit card sales in North America, and (iii) Australia building lease collateral. As of September 30, 2009 and December 31, 2008, our total restricted cash was $9.4 million./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Accounts Receivable/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT- FAMILY: Times New Roman"Accounts receivable are carried at their estimated collectible amounts. Receivables are created upon shipment of an order if the credit card payment is rejected or does not match the order total. As of September 30, 2009 and December 31, 2008, receivables consisted primarily of amounts due from members and associates. The Company periodically evaluates its receivables for collectability based on historical experience, recent account activities, and the length of time receivables are past due, and writes-off receivables when they become uncollectible. At September 30, 2009 and December 31, 2008, the Company held an allowance for doubtful accounts of less than $0.1 million./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Inventories/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Inventories consist of raw materials, work in progress, finished goods, and promotional materials that are stated at the lower of cost (using standard costs that approximate average costs) or market. The Company periodically reviews inventories for obsolescence and any inventories identified as obsolete are reserved or written off./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Other Assets/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"As of September 30, 2009 and December 31, 2008, other assets of $2.5 million and $1.5 million primarily consisted of deposits for contracts and building leases in various locations./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Commissions and Incentives/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Independent associates earn commissions and incentives based on their direct and indirect commissionable net sales over 13 business periods. Each business period equals 28 days. The Company accrues commissions and incentives when earned by independent associates and pays commissions on product sales three weeks following the business period end and pays commissions on its pack sales five weeks following the business period end./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left" gt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Other Long-Term Liabilities/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"In August 2003, the Company entered into a Long-Term Post-Employment Royalty Agreement with Dr.#160;Bill#160;McAnalley, the Company#8217;s former Chief Science Officer, pursuant to which the Company is required to pay Dr.#160;McAnalley, or his heirs, royalties for ten years beginning September 2005 through August 2015. Quarterly payments related to this Long-Term Post-Employment Royalty Agreement are based on certain applicable annual global product sales by the Company in excess of $105.4 million. At the time the Company entered into this Long-Term Post-Employment Royalty Agreement, it was considered a post-employment benefit and the Company was required to measure and accrue the present value of the estimated future royalty payments related to the post-employment royalty benefit and recognize it over the life of Dr.#160;McAnalley#8217;s employment agreement, which was two years. As of September 30, 2009, the Company#8217;s liability related to this royalty agreement was $2.1 million, of which $0.3 million was currently due and included in accrued expenses.#160;#160;As of December#160;31, 2008, the Company#8217;s long-term liability related to this royalty agreement was $2.4 million, of which $0.4 million was currently due and included in accrued expenses./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TE XT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Certain operating leases for the Company#8217;s regional office facilities contain a restoration clause that requires the Company to restore the premises to its original condition. As of September 30, 2009 and December 31, 2008, accrued restoration costs related to these leases amounted to $0.4 million. At September 30, 2009 and December 31, 2008, the Company also recorded a long-term liability for an estimated deferred benefit obligation related to a deferred benefit plan for its Japan operations of $0.8 million./font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; FONT-SIZE: 10pt; TEXT-DECORATION: underline"Comprehensive Incom e (loss) and Accumulated Other Comprehensive Income (Loss/fontfont style="DISPLAY: inline; TEXT-DECORATION: underline")/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Comprehensive income (loss) is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from nonowner sources and includes all changes in equity during a period except those resulting from investments by owners and distributions to owners. The Company#8217;s comprehensive income (loss) consists of the Company#8217;s net income (loss), foreign currency translation adjustments from its Japan, Republic of Korea, Taiwan, Norway, and Sweden operations, and changes in the pension obligatio n for its Japanese employees./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Revenue Recognition/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company#8217;s revenue is derived from sales of its products, sales of its starter and renewal packs, and shipping fees. Substantially all of the Company#8217;s products are sold to independent associates at published wholesale prices and to members at discounted published retail prices. The Company recognizes revenue upon receipt of packs and products by its customers. The Company records revenue net of any sales taxes and records a reserve for expected sales returns based on its historical experience./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company defers certain components of its revenue. Total deferred revenue consists of revenue received from: (i) sales of packs and products, which were shipped but not received by customers by period end; (ii) one-year magazine subscriptions; (iii) pack sales when the pack sale price exceeds the wholesale value of all individual components within the pack; and (iv) prepaid registration fees from customers planning to attend a future co rporate-sponsored event. The Company recognizes deferred revenue from shipped packs and products upon receipt by the customer. Corporate-sponsored event revenue is recognized when the event is held. All other deferred revenue is recognized ratably over one year. Components of deferred revenue were as follows:/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div align="left" table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr td valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/fon t/td td colspan="2" valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"September 30, 2009/font/div /td td nowrap="nowrap" valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" bgcolor="#ffffff" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block ; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"December#160;31,#160;2008/font/div /td td nowrap="nowrap" valign="bottom" bgcolor="#ffffff" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td valign="bottom" bgcolor="#ffffff"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td valign="bottom"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"#160;/font/td td colspan="6" valign="bottom" bgcolor="#ffffff" div style="DISPL AY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"(in thousands)/font/div /td td nowrap="nowrap" valign="bottom" bgcolor="#ffffff" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Revenue related to undelivered packs and products/font/div /td td align="right" valign="bottom" width="1%"font style="DIS PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3,779/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/f ont/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3,228/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Revenue related to a one-year magazine subscription and pack sales/font/div div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" ;exceeding the wholesale value of individual components sold/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"93/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" #160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"133/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Revenue related to future corporate-sponsored events/ font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"20/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"115/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total deferred revenue/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3,892/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="D ISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3,476/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times n ew roman"#160;/font/td /tr/table /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"We estimate a sales return reserve for expected sales refunds based on our historical experience over a rolling six month period. If actual results differ from our estimated sales returns reserves due to various factors, the amount of revenue recorded each period could be materially affected. Historically, our sales returns have not materially changed through the years as the majority of our customers return their merchandise within the first 90 days after the original sale. Sales returns have averaged 1.5% or less of our gross sales. As of September 30, 2009 our sales return reserve was composed of the following (in thousands): /font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div align="left" table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"font style="DISPLAY: in line; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"September 30, 2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="88%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Sales reserve as of January 1, 2009/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-A LIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"719/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="88%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Provision related to sales made in current period/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inl ine; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2,475/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="88%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Provision related to sales m ade in prior periods/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"106/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="88%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDEN T: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Actual returns or credits related to current period/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(1,886 /font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td /trtr bg color="#eeeeee" td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Actual returns or credits related to prior periods/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(808 /font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Sales reserve as of September 30, 2009/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font s tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"606/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /tr/table /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Shipping and Handling Costs/font ;/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company records freight and shipping fees collected from its customers as revenue. The Company records inbound freight as cost of sales and records shipping and handling costs associated with shipping products to customers as selling and administrative expenses. Total shipping and handling costs included in selling and administrative expenses were approximately $3.6 million and $3.4 million for the three months ended September 30, 2009 and 2008, respectively, and $10.6 and $11.2 million for the nine months ended September 30, 2009 and 2008, respectively./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN- LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Reclassifications/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Certain reclassifications have been made to the financial statements for prior periods to conform to the current period presentation./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div /div

LOSS PER SHARE	9 Months Ended
LOSS PER SHARE	Sep. 30, 2009
Notes To Financial Statements [Abstract]
Loss Per Share	div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"NOTE 4: LOSS PER SHARE/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Basic Earnings (Loss) Per Share (#8220;EPS#8221;) calculations are based on the weighted-average number of the Company#8217;s common shares outstanding during the period. Diluted EPS calculations are based on the calculated weighted-average number of common shares and dilutive common share equivalents outstanding during each period./font/div div style="DISPLAY: block; MAR GIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The following data shows the amounts used in computing the Company#8217;s EPS and their effect on the Company#8217;s weighted-average number of common shares and dilutive common share equivalents for the three months ended September 30, 2009 and 2008. For the three months ended September 30, 2009, approximately 1.6 million shares of the Company#8217;s common stock subject to options were excluded from diluted EPS calculations using an average close price of $3.73 per share, as their effect was antidilutive. For the three months ended September 30, 2008, 1.5 million shares of the Company#8217;s common stock subject to options were excluded from diluted EPS calculations using an average close price of $5.20 per share, as their effect was antidilutive. The amounts below are rounded to the nearest thousands, except for per share amo unts./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div div div table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="23" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"For the three months ended September 30,/font/div /td td nowrap="nowrap" valign="bottom" style=" PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="11" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="11" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2008/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Loss/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(numerator)/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" d iv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Shares/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(denominator)/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIG HT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Per share/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"amount/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Loss/font/div div style="DISPLAY: block; MARGI N-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(numerator)/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Shares/font ;/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(denominator)/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Per share/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"f ont style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"amount/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"font style="DISPLAY: inline"Basic EPS:/font/font/div /td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font ;/td td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; ;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="28%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Net loss available to/font/div div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"common shareholders/ font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(9,207/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td t d valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"26,464/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: ri ght"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(0.35/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(429/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE : 10pt; FONT-FAMILY: times new roman")/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"26,461/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font gt;/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(0.02/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="28%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Effect of dilutive securities:/font/div div style="DISPLAY: b lock; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Stock options/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1% " style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"f ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="28%" style="BORDER-BOTTOM : black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"font style="DISPLAY: inline"Diluted EPS:/font/font/div /td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign ="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" p;#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEX T-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Net loss available to/font/div div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time s new roman"common shareholders plus/font/div div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"assumed conversions/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(9,207/font/td lt;td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"26,464/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4p x; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(0.35/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/ font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(429/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: in line; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"26,461/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT - -FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(0.02/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td /tr/table /div /div /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEF T: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The following data shows the amounts used in computing the Company#8217;s EPS and their effect on the Company#8217;s weighted-average number of common shares and dilutive common share equivalents for the nine months ended September#160;30, 2009 and 2008. For the nine months ended September 30, 2009, approximately 1.5 million shares of the Company#8217;s common stock subject to options were excluded from diluted EPS calculations using an average close price of $3.48 per share, as their effect was antidilutive. For the nine months ended September 30, 2008, approximately 1.4 million shares of the Company#8217;s common stock subject to options were excluded from diluted EPS calculations using an average close price of $6.11 per share, as their effect was antidilutive. The amounts below are rounded to the nearest thousands, except for per share amounts./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div div table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="23" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"For the nine months ended September 30,/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; T EXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="11" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="11" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2008/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font styl e="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Loss/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(numerator)/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Shares/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(denominator)/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Per share t;/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"amount/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Loss/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style=" DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(numerator)/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Shares/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; M ARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(denominator)/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Per share/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"amount ;/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td align="left" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"font style="DISPLAY: inline"Basic EPS:/font/font/div /td td colspan="3" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" gt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="28%" div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Net loss available to/font/div div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="lef t"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"common shareholders/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(19,519/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FON T-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"26,462/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$ ;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(0.74/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(13,248/font/td td nowrap="nowrap" valign="botto m" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"26,461/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inli ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(0.50/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="28%" div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Effect of dilutive securities:/fo nt/div div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Stock options/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style= "TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"fo nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="28%" style="BORDER- BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"font style="DISPLAY: inline"Diluted EPS:/font/font/div /td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bott om" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/fo nt/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time s new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style=" DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="PADDING - -BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Net loss available to/font/div div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"common shareholders plus/font /div div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"assumed conversions/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(19,519/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-B OTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"26,462/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bol d; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(0.74/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(13,248/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; ;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"26,461/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" sty le="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"(0.50/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman")/font/td /tr/table /div /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div /div

STOCK BASED COMPENSATION	9 Months Ended
STOCK BASED COMPENSATION	Sep. 30, 2009
Notes To Financial Statements [Abstract]
Stock-Based Compensation	div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"NOTE 5: STOCK-BASED COMPENSATION/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company currently has one active stock-based compensation plan, which was approved by shareholders. The Company generally grants stock options to employees, consultants, and board members at the fair market value of its common stock, on the date of grant, with a term no greater than ten years. The stock options generally vest over two or three years. Incentive stock options granted to shareholders owning 10% or more of the Company#8217;s outstanding stock have an exercise price which may not be less than 110% of the fair market value of the Company#8217;s common stock on the date of the grant and a term no greater than five years./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"In February 2008, the Company#8217;s Board of Directors approved the Mannatech, Incorporated 2008 Stock Incentive Plan (the #8220;2008 Plan#8221;) which reserved, for issuance of stock options and restricted stock to employees, board members, and consultants, up to 1,000,000 shares of common stock plus any shares reserved under the Company#8217;s then-existing, unexpired stock plan for which options had not yet been issued plus any shares underlying outstanding options under the then-existing stock option plan that terminate without having been exercised in full. The 2008 Plan was approved by the Company#8217;s shareholders at the 2008 Annual Shareholders#8217; Meeting held on June 18, 2008. As of September 30, 2009, the 2008 Plan had 390,507 stock options available for grant./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company records stock-based compensation expense related to granting stock options in selling and administrative expenses. During each of the three months ended September 30, 2009 and 2008, the Company granted 30,000 stock options. During the nine months ended September 30, 2009 and 2008, the Company granted 305,000 a nd 376,095 stock options, respectively. The fair values of stock options granted during the nine months ended September 30, 2009 ranged from $1.24 to $2.01 per share. The fair value of stock options granted during the nine months ended September 30, 2008 ranged from $1.85 to $2.81 per share. The Company recognized compensation expense as follows for the periods ended September 30:/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div align="left" table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr bgcolor="#ffffff" td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="7" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Three months/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="7" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Nine months/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; F ONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#ffffff" td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2008/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZ E: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2008/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#ffffff" td valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="7" valign="bottom" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGI N-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"(in thousands)/font/div /td td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"#160;/font/td td colspan="7" valign="bottom" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"(in thousands)/font/div /td td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"#160; lt;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="52%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total gross compensation expense/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"125/fon t/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"163/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10 pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"437/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font st yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"576/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISP LAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total tax benefit associated with compensation expense/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"24/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; lt;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"31/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inli ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"97/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BO RDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"116/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total net compensation expense/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"101/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"132/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4p x double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"340/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"460/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /tr/table /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"As of September 30, 2009, the Company expects to record compensation expense in the future as follows:/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div div table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="3" valign="bottom" style="PADDING-BOTTOM: 2px; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Three months/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"ending/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="11" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Year ending December 31,/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times n ew roman"#160; /font/td td colspan="3" valign="bottom" style="PADDING-BOTTOM: 2px; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" /div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"December 31,/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2010/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2011/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2012/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="52%" div style="DISPLAY: block ; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total gross unrecognized compensation expense/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"109/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"342/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left" t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"191/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"23/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Tax benefit associated with unrecognized compensation expense/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"19/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"63/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FON T-SIZE: 10pt; FONT-FAMILY: times new roman"35/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total net unrecognized compensation expense/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/ font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"90/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font styl e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"279/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"156/font/td td nowrap="nowrap" valign= "bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"22/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new r oman"#160;/font/td /tr/table /div /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div /div

FAIR VALUE	9 Months Ended
FAIR VALUE	Sep. 30, 2009
Notes To Financial Statements [Abstract]
Fair Value	div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"NOTE 8: FAIR VALUE/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company utilizes fair value measurements to record fair value adjustments to certain financial assets and to determine fair value disclosures./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT - -FAMILY: Times New Roman"Fair Value Measurements and Disclosure Topic of the FASB ASC establishes a fair value hierarchy that requires the use of observable market data, when available, and prioritizes the inputs to valuation techniques used to measure fair value in the following categories:/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; FONT-FAMILY: Symbol, serif"#183;/font#160;#160;#160;#160;#160;#160;Level 1#8212;Quoted unadjusted prices for identical instruments in active markets./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //di v div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; FONT-FAMILY: Symbol, serif"#183;/font#160;#160;#160;#160;#160;#160;Level 2#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active and model-derived valuations in which all observable inputs and significant value drivers are observable in active markets./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; FONT-FAMILY: Symbol, serif"#183;/font# 160;#160;#160;#160;#160;#160;Level 3#8212;Model-derived valuations in which one or more significant inputs or significant value drivers are unobservable, including assumptions developed by the Company./font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The primary objective of the Company#8217;s investment activities is to preserve principal while maximizing yields without significantly increasing risk. The investment instruments held by the Company are money market funds and interest bearing deposits for which quoted market prices are readily available. The Company considers these highly liquid investments to be cash equivalents. These investments are classified within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The table below presents the recorded amount of financial assets measured at fair value on a recurring basis as of September 30, 2009. The Company does not have any material financial liabilities or nonfinancial assets and liabilities that were required to be measured at fair value on a recurring basis at September 30, 2009./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div align="left" table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" tr bgcolor="#ffffff" td align="left" valign="bottom" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" ;Asset/font/div /td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Level 1/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new r oman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Level 2/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Level 3/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total/font/div /td td no wrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="52%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Money Market Funds #8211; Fidelity, US/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom " width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"6,264/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font sty le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" #160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"6,264/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Interest bearing deposits #8211; various banks, Korea/font /div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"7,723/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font styl e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bot tom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMI LY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"7,723/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 27pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total assets/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="D ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"13,987/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" t;$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"fo nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"13,987/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="52%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Amounts included in:/font/div /td td valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMIL Y: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%"font style="DI SPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="52%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Cash and cash equivalents/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"7,833/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td v align="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DIS PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"7,833/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Long-term restricted cash/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISP LAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"6,154/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign= "bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim es new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"6,154/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign= "bottom" width="52%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Total/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"13,987/font/td td nowrap="nowrap" valign="bottom" width="1%" style ="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/ font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline ; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"13,987/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /tr/table /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div /div

SEGMENT INFORMATION	9 Months Ended
SEGMENT INFORMATION	Sep. 30, 2009
Notes To Financial Statements [Abstract]
Segment Information	div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"NOTE 9: SEGMENT INFORMATION/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company conducts its business as one operating segment, consolidating all of its business units into a single reportable entity, as a seller of proprietary nutritional supplements, topical and skin care products, and weight-management products through its network-marketing distribution channels operating in sixteen countries. Each of the Company#8217;s business units sells similar packs a nd products and possesses similar economic characteristics, such as selling prices and gross margins. In each country, the Company markets its products and pays commissions and incentives in similar market environments. The Company#8217;s management reviews its financial information by country and focuses its internal reporting and analysis of revenues by packs and product sales. The Company sells its products through its independent associates and distributes its products through similar distribution channels in each country. No single independent associate has ever accounted for more than 10% of the Company#8217;s consolidated net sales./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company operates in eight physical locations and se lls product in sixteen different countries around the world. The eight physical locations are the United States, Canada, Switzerland, Australia, the United Kingdom, Japan, the Republic of Korea (South Korea), and Taiwan. Each of the Company#8217;s physical locations services different geographic areas. The United States location processes orders for the United States and Canada. The Canadian location provides administrative support to the Canadian market and acts as a meeting location for independent associates. The Australian location processes orders for Australia, New Zealand, and Singapore. The Company#8217;s United Kingdom location processes orders for the United Kingdom, Denmark, Germany, Austria, the Netherlands, Norway, and Sweden. The Company#8217;s Switzerland office manages certain day-to-day business needs of non-North American markets and coordinates the Company#8217;s continued global expansion./font/div div style="DISPLAY: block; MARGIN - -LEFT: 0pt; TEXT-INDENT: 45pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Consolidated net sales shipped to customers in these locations, along with pack and product information for the three and nine months ended September 30, 2009 and 2008 are as follows (in millions, except percentages):/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div div table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA MILY: times new roman"#160;/font/td td colspan="14" valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Three months/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="14" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"font style="DISPLAY: inline; FONT-SIZE: 10pt"Nine/font font style="DISPLAY: inline; FONT-SIZE: 10pt"months/font/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr td align="left" valign="bottom" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Country/font/div /td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td lt;td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2008/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font sty le="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2008/font/div /td td nowrap="nowrap" valign="bottom" style="PAD DING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="20%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"United States/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style ="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"34.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"47.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA MILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"40.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"51.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style= "DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"109.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"49.9/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA MILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"137.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"53.6/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="20%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Japan/font/div /td td align="right" valign="bottom" width="1%"font style="D ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"9.9/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne w roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"13.9/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"10.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"13.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%" lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"31.4/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT - -FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"14.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"33.9/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"13.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td /trtr bgcolor="#eeeeee" t; td align="left" valign="bottom" width="20%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Republic of Korea/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"6.9/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY : inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"9.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"8.4/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bott om" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"10.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"19.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"8.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" ;#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"27.4/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td ;td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"10.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="20%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Canada/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font styl e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"5.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim es new roman"8.1/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"5.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"7.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left" font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"17.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FO NT-FAMILY: times new roman"8.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"17.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font ;/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"6.9/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="20%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"f ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Australia/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"5.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"8.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font lt;/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"6.4/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"8.2/font/td td nowrap="nowrap" valign="bott om" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"16.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inlin e; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"7.6/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"20.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"8.1/font/td td nowrap="nowra p" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="20%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"South Africafont style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"(1)/font/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3.9/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"5.5/font/td td nowrap="nowrap" valign="bottom" width=" 1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE : 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2.6/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font ;/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"9.4/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"4.2/font/td td nowrap="nowrap" valign="bo ttom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3.4/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inli ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="20%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Taiwan/font/div t; /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.4/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLA Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time s new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"4.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td va lign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.4/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT - -FAMILY: times new roman"%/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="20%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"New Zealand/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.1/font/td t d nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%" lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT- FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" wi dth="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"4.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE : 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.6/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="20%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Germany/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/t d td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.9/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/f ont/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2.6/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom " width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font sty le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="20%" div style="DISP LAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"United Kingdomfont style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"(2)/font/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FON T-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font /td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7% " style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.6/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY : inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.1/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bott om" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="20%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Denmark/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: in line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" gt;0.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td t;td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.4/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style ="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time s new roman"0.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.9/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.4/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="20%" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left "font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Singaporefont style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"(3)/font/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.4/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font s tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.6/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" v align="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times n ew roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"1.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font /td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY : inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#8212;/font/td td nowrap="no wrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="20%" style="PADDING-BOTTOM: 4px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Totals/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT- SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"71.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font gt;/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"100/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="7%" style="BORDE R-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"78.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"fo nt style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"100/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"219.6/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"100/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"256.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING- BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"100/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY : inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"%/font/td /tr/table /div /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"_________________________/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"(1)/font South Africa began operations in May 2008./font/div div align="center" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" table border="0" cellpadding="0" cellspacing="0" id="hangingindent_0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: ; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr valign="top" td align="right" style="WIDTH: 9pt" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"(2)/font/font/div /td td align="left" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Net Sales for Austria, the Netherlands, Norway, and Sweden are included in the United Kingdom net sales total. We began operations in these four countries in Septe mber 2009./font/div /td /tr/table /div /div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"(3) /fontSingapore began operations in November 2008./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div align="left" table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr bgcolor="#ffffff" td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="7 " valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Three months/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline ; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Nine months/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#ffffff" td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div /td td nowrap="nowrap" valign="bottom" st yle="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2008/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" vali gn="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2008/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#ffffff" td valign="bottom"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td colspan="7" valign="bottom" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"(in millions)/font/div /td td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"font style="DISPLAY: inline; F ONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"#160;/font/td td colspan="6" valign="bottom" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"(in millions)/font/div /td td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="52%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Consolidated product sales/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"52.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style= "DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"61.1/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PAD DING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"159.1/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom " width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"199.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="52%" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Consolidated pack sales/font/div /td td align="rig ht" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"15.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inli ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"13.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"50.2 /font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"45.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trt r bgcolor="#eeeeee" td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Consolidated other, including freight/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" gt;3.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"3.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"10.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align= "right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"11.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px" div style ="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Consolidated total net sales/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"71.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"78.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font styl e="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"219.6/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: tim es new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"256.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /tr ;/table /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 24.5pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Long-lived assets, which include property and equipment and construction in progress for the Company and its subsidiaries, reside in the following countries, as follows:/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div align="left" table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" tr bgcolor="#ffffff" td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td ;td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"September 30,/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2009/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160 ;/font/td td valign="bottom" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"December 31,/font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"2008/font/div /td td nowrap="nowrap" valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FO NT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#ffffff" td align="left" valign="bottom" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Country/font/div /td td valign="bottom"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"#160;/font/td td colspan="6" valign="bottom" div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"(in millions)/font/div /td td nowrap="now rap" valign="bottom" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Australia/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right" ;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time s new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Japan/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.3/font/td td nowrap="nowrap" valign="b ottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bo ttom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Republic of Korea/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.5/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman" ;#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align ="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Switzerland/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.6/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT- SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.7/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"Taiwan/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.1/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-AL IGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.1/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td align="left" valign="bottom" width="76%" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"United Kingdom/font/div /td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT- FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.1/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"0.1/font/td td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="#eeeeee" td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px" div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"United States/font/div /td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td lt;td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"28.3/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"34.8/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /trtr bgcolor="white" td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160; /font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="botto m" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"30.2/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" t;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"$/font/td td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"37.0/font/td td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"#160;/font/td /tr/table /div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div /div

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2009	Sep. 30, 2008	Sep. 30, 2009	Sep. 30, 2008
Statement [Line Items]
Net sales	$ 71,295	$ 77,991	$ 219,640	$ 256,223
Cost of sales	11,923	11,105	35,944	37,014
Commissions and incentives	35,268	32,396	115,413	116,256
Total cost of sales	47,191	43,501	151,357	153,270
Gross profit	24,104	34,490	68,283	102,953
Operating expenses:
Selling and administrative	17,748	18,753	53,403	63,349
Depreciation and amortization	3,085	3,172	9,357	9,225
Other operating	11,842	11,493	30,831	49,530
Total operating expenses	32,675	33,418	93,591	122,104
Income (loss) from operations	(8,571)	1,072	(25,308)	(19,151)
Interest income	39	266	182	1,219
Other income (expense), net	859	(2,047)	822	(2,450)
Loss before income taxes	(7,673)	(709)	(24,304)	(20,382)
(Provision) benefit for income taxes	(1,534)	280	4,785	7,134
Net loss	$ (9,207)	$ (429)	$ (19,519)	$ (13,248)
Loss per share:
Basic	$ (0.35)	$ (0.02)	$ (0.74)	$ (0.50)
Diluted	$ (0.35)	$ (0.02)	$ (0.74)	$ (0.50)
Weighted-average common shares outstanding:
Basic	26,464	26,461	26,462	26,461
Diluted	26,464	26,461	26,462	26,461

CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2009	Sep. 30, 2009
Statement [Line Items]
Balance - beginning of period		$ 68,729
Tax shortfall from expiration of stock options		(13)
Proceeds from stock options exercised		66
Charge related to stock based compensation		437
Declared dividends of $0.04 per common share		(1,058)
Components of comprehensive loss:
Foreign currency translations		276
Net loss	$ (9,207)	(19,519)
Total comprehensive loss		(19,243)
Balance - end of period	48,918	48,918
Common Stock Outstanding
Statement [Line Items]
Balance - beginning of period		$ 3
Balance - beginning of period (in shares)		26,461
Tax shortfall from expiration of stock options		$ 0
Proceeds from stock options exercised (in shares)		20
Charge related to stock based compensation		$ 0
Declared dividends of $0.04 per common share		0
Components of comprehensive loss:
Foreign currency translations		0
Net loss		0
Balance - end of period	$ 3	$ 3
Balance - end of period (in shares)	26,481	26,481
Additional paid in capital
Statement [Line Items]
Balance - beginning of period		$ 40,753
Tax shortfall from expiration of stock options		(13)
Proceeds from stock options exercised		66
Charge related to stock based compensation		437
Declared dividends of $0.04 per common share		0
Components of comprehensive loss:
Foreign currency translations		0
Net loss		0
Balance - end of period	$ 41,243	41,243
Retained Earnings
Statement [Line Items]
Balance - beginning of period		44,170
Tax shortfall from expiration of stock options		0
Charge related to stock based compensation		0
Declared dividends of $0.04 per common share		(1,058)
Components of comprehensive loss:
Foreign currency translations		0
Net loss		(19,519)
Balance - end of period	23,593	23,593
Accumulated other comprehensive loss
Statement [Line Items]
Balance - beginning of period		(1,406)
Tax shortfall from expiration of stock options		0
Charge related to stock based compensation		0
Declared dividends of $0.04 per common share		0
Components of comprehensive loss:
Foreign currency translations		276
Net loss		0
Total comprehensive loss		0
Balance - end of period	(1,130)	(1,130)
Treasury stock
Statement [Line Items]
Balance - beginning of period		$ (14,791)
Balance - beginning of period (in shares)		1,207
Tax shortfall from expiration of stock options		$ 0
Charge related to stock based compensation		0
Components of comprehensive loss:
Balance - end of period	$ (14,791)	$ (14,791)
Balance - end of period (in shares)	1,207	1,207

PARENTHETICAL DATA TO CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY AND COMPREHENSIVE INCOME (LOSS)	9 Months Ended
	Sep. 30, 2009 $ / shares
Statement [Line Items]
per common share (in dollars per share)	$ 0.04

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2009	Sep. 30, 2008
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (19,519)	$ (13,248)
Adjustments to reconcile net loss to net cash used in operating ativities:
Depreciation and amortization	9,357	9,225
Provision for doubtful accounts	(7)	34
Provision for inventory losses	821	1,142
Loss on disposal of assets	94	468
Accounting charge related to stock-based compensation	437	597
Deferred income taxes	(1,556)	(3,150)
Changes in operating assets and liabilities:
Accounts receivable	12	298
Income tax receivable	517	(3,593)
Inventories	1,265	(6,890)
Prepaid expenses and other current assets	2,220	2,410
Other assets	(1,022)	(39)
Accounts payable	1,630	(630)
Accrued expenses	(2,635)	3,636
Taxes payable	774	(5,635)
Commissions and incentives payable	2,505	(1,721)
Deferred revenue	399	(906)
Net cash used in operating activities	(4,708)	(18,002)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(2,500)	(4,452)
Sale of investments	0	20,350
Purchase of investments	0	(7,400)
Change in restricted cash	389	1,610
Net cash provided by (used in) investing activities	(2,111)	10,108
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment of cash dividends	1,058	5,293
Proceeds from stock options	66	0
Repayment of capital lease obligations	273	82
Net cash used in financing activities	(1,265)	(5,375)
Effect of exchange rate changes on cash and cash equivalents	(284)	1,148
Net decrease in cash and cash equivalents	(8,368)	(12,121)
Cash and cash equivalents at the beginning of period	30,945	47,103
Cash and cash equivalents ant the end of period	22,577	34,982
SUPPLIMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Income taxes paid (refund received)	(2,721)	2,546
Interest paid on capital leases	$ 29	$ 13

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2009
Notes To Financial Statements [Abstract]
Income Taxes	div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"NOTE 3: INCOME TAXES/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"For the three months and nine months ended September 30, 2009, the Company#8217;s effective tax rate was 20.0% and 19.7%, respectively. For the three months and nine months ended September 30, 2008, the Company#8217;s effective tax rate was 39.5% and 35.0%, respectively. The decrease for the three and nine months ended September 30, 2009 as compared to the same periods in 2008 was primarily due to add itions to the valuation allowance for deferred tax assets in response to continued operating losses and the uncertainty associated with forecasting future operating results in the current economic environment./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div /div

PARENTHETICAL DATA TO THE CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2009	Dec. 31, 2008
ASSETS
Allowance for doubtful Accounts Receivable	$ 16,000	$ 23,000
Shareholders' equity
Preferred stock, $0.01 par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock - shares issued	0	0
Preferred stock - shares outstanding	0	0
Common stock, $0.0001 par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	99,000,000	99,000,000
Common stock, shares issued	27,687,882	27,667,882
Common stock, shares outstanding	26,480,788	26,460,788
Treasury stock, shares in 2009 and 2008	1,207,094	1,207,094

INVENTORIES	9 Months Ended
INVENTORIES	Sep. 30, 2009
Notes To Financial Statements [Abstract]
Inventories	NOTE 2: INVENTORIES Inventories consist of raw materials, work in progress, and finished goods, including promotional materials. Work in progress includes raw materials shipped to a third-party manufacturer to process into certain finished goods. The Company provides an allowance for any slow-moving or obsolete inventories. Inventories at September 30, 2009 and December 31, 2008, consisted of the following:

LITIGATION	9 Months Ended
LITIGATION	Sep. 30, 2009
Notes To Financial Statements [Abstract]
Litigation	div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"NOTE 6: LITIGATION/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Patent Infringement Litigation/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT- SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Mannatech, Inc. v. K.Y.C. Inc. d/b/a Techmedica Health Inc., Triton Nutra, Inc., Ionx Holdings, Inc., and John Does 1-30/font, Case No. 3-06-CV-0471-BD (N.D. Tex.)/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company filed a patent infringement lawsuit against K.Y.C. Inc. d/b/a Techmedica Health, Inc. (#8220;Techmedica#8221;), Triton Nutra, Inc., Ionx Holdings, Inc. (#8220;Ionx#8221;), and John Does 1-30, pending in the United States District Court of the Northern District of Texas, Dallas Division. The lawsuit alleges the defendants infringed United States Patent Nos. 6,929,807, 7,157,431, 7,196,064, 7,199,104, and 7,202,220, all entitled #8220;Compositions of Plant Carbohydrates as Dietary Supplements,#8221; and seeks to stop the manufacture, offer, and sale of defendants#8217; infringing glyconutritional products, as well as cessation of defendants#8217; false advertising about our products, including Ambrotosefont style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"#174;/font./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"On May 5, 2006, the Company initiated the lawsuit against Techmedica, alleging infringement of the #8216;807 Patent. After Techmedica claimed that Triton Nutra manufactured its glyconutritional products, the Company amended its complaint on February 6, 2007 to add Triton Nutra as a defendant, as well as infringement claims related to the newly issued #8216;431 Patent against both Techmedica and Triton Nutra. When Triton Nutra failed to answer the Amended Complaint, the Company requested, and the Clerk of Court entered, default against Triton Nutra on May 3, 2007./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"On August 10, 2007, the Court stayed the case pending entry of judgment in the Company#8217;s earlier patent infringement suit against Glycoproducts International, Inc. f/k/a Glycobiotics International, Inc. (#8220;Glycobiotics#8221;). During the stay, on February 28, 2008, a federal grand jury indicted Techmedica Health and its president for violations of federal drug distribution laws, wire and mail fraud, and money laundering. The government is seeking any property derived from these activities, including over $17 million in cash and various real estate and other property. After the indictment, Ionx purchased all of the assets of Techmedica, including its inventory of glyconutritional products, and began selling these products on the internet under the assumed name Micronutra Health./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"Following the Company#8217;s successful prosecution of its patent infringement suit against Glycobiotics, on July 30, 2008, the Court granted its unopposed motion to lift the stay in this suit. The Company filed its Second Amended Complaint on September 18, 2008, adding Ionx and John Does 1-30 as defendants and i nfringement claims related to the #8216;064, #8216;104, and #8216;220 Patents, and naming Activive as an additional infringing glyconutritional product. In the Company#8217;s preliminary infringement contentions, it identified nine infringing products: Nutratose, Activive, Candidol, Claritose, Lupazol, Respitrol, Rhumatol, Synaptol, and Viratrol. In its deposition on October 10, 2008, Techmedica#8217;s corporate representative testified that all nine identified products are comprised of the same encapsulated ingredients.#160;#160;On October 13, 2008, Techmedica and Ionx filed identical answers and counterclaims, which claim that the Company#8217;s patents-in-suit are invalid, unenforceable, or otherwise not infringed by defendants./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style= "DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"On August 28, 2009, in response to Defendants#8217; motion for claim construction, the United States Magistrate Judge issued Findings and Recommendations construing three disputed claim terms in the patents-in-suit.#160;#160;Defendants have objected to two of the Magistrate Judge#8217;s recommended constructions, and the parties are briefing the Court on this issue.#160;#160;After the Court rules on these objections, the parties will jointly submit a proposed scheduling order to continue the discovery process and set a trial date./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company will continue to vigorously prosecute this case. Given the precedent set by font style="DISPLAY: inline; FONT-STYLE: italic"Mannatech v. Glycobiotics/font, the Company believes the likelihood of an unfavorable outcome is remote, and with no counterclaims seeking monetary damages, any potential loss is limited to an award of the defendants#8217; court costs./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Mannatech, Inc. v. Boston Mountain Laboratories, Green Life, LLC, and Xiang Lo/font, Case Nofont style="DISPLAY: inline; FONT-STYLE: italic". /font3:09-CV-01324-G (N.D. Tex)/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: blo ck; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company filed a patent infringement lawsuit against Boston Mountain Laboratories d/b/a Natural Health Warehouse (#8220;Boston Mountain#8221;), Green Life, LLC (#8220;Green Life#8221;), and Xiang Lo a/k/a Andrew Lo (#8220;Lo#8221;) on July 15, 2009.#160;#160;The matter is pending in the United States District Court of the Northern District of Texas, Dallas Division. The lawsuit alleges the defendants infringed United States Patent Nos. 6,929,807, 7,157,431, 7,196,064, 7,199,104, and 7,202,220, all entitled #8220;Compositions of Plant Carbohydrates as Dietary Supplements,#8221; and seeks to stop Boston Mountain and Green Life from manufacturing, offering for sale, and selling of defendants#8217; infringing glyconutritional products. Xiang Lo is the sole member of Green Life, and it is b elieved that Green Life was organized and is operated as an alter ego, i.e., a mere tool or business conduit, of Andrew Lo./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"On September 23, 2009, the Court granted a joint motion for entry of final judgment and permanent injunction, entering judgment for the Company and against Boston Mountain Laboratories, Inc.#160;#160;The Final Judgment and Permanent Injunction enjoins Boston Mountain Laboratories for the duration of the patents-in-suit from (1) manufacturing or selling BML Glyconutrient Formula, Glyco-8, Glycoessentials, Glyco-Essence, Glyconutrients, MG-3, and MG-3c (the #8220;Enjoined Products#8221;); (2) inducing infringement of the patents-in-suit; or (3) supplying or causing to be supplied in or from the United States all or a substantial portion of the components of the Enjoined Products./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"After Green Life, LLC and Xiong Lo failed to answer the Company#8217;s Complaint, on September 30, 2009, the Deputy Clerk of Court entered default against Green Life and Mr. Lo.#160;#160;The Company is now preparing its motion for entry of default judgment against them, which will seek the same injunctive relief secured against Boston Mountain./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPL AY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; TEXT-DECORATION: underline"Litigation in General/font/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The Company has several pending claims incurred in the normal course of business. In the Company#8217;s opinion, such claims can be resolved without any material adverse effect on its consolidated financial position, results of operations, or cash flows./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZ E: 10pt; FONT-FAMILY: Times New Roman"The Company maintains certain liability insurance; however, certain costs of defending lawsuits, such as those below the insurance deductible amount, are not covered by or only partially covered by its insurance policies, or its insurance carriers could refuse to cover certain of these claims in whole or in part. The Company accrues costs to defend itself from litigation as it is incurred or as it becomes determinable./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The outcome of litigation may not be assured, and despite management#8217;s views of the merits of any litigation, or the reasonableness of the Company#8217;s estimates and reserves, the Company#8217;s financial statements could nonet heless be materially affected by an adverse judgment. The Company believes it has adequately reserved for the contingencies arising from the above legal matters where an outcome was deemed to be probable, and the loss amount could be reasonably estimated. While it is not possible to predict with certainty what liability or damages the Company might incur in connection with any of the above-described lawsuits, based on the advice of counsel and a management review of the existing facts and circumstances related to these lawsuits, the Company has accrued $5.7 million as of September 30, 2009 for these matters, which is included in accrued expenses in its Consolidated Balance Sheet. Included in this amount is a $5.5 million accrual related to the Company#8217;s settlement with the Texas Attorney General in early 2009. As part of the settlement, the Company agreed to refund up to $4.0 million to purchasers of the Company#8217;s products between September 1, 2002 and August 1, 2007 who have not received commissions. Also included in the accrual is the Company#8217;s estimate for a third-party claim administration fee associated with this matter./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div /div

RECENT ACCOUNTING PRONOUNCEMENTS	9 Months Ended
RECENT ACCOUNTING PRONOUNCEMENTS	Sep. 30, 2009
Notes To Financial Statements [Abstract]
Recent Accounting Pronouncements	div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"NOTE 7: RECENT ACCOUNTING PRONOUNCEMENTS/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"In June#160;2009, the Financial Accounting Standards Board (FASB) approved the font style="DISPLAY: inline; FONT-STYLE: italic"#8220;FASB Accounting Standards Codification#8221;/font (#8220;Codification#8221;, #8220;FASB ASC#8221;) as the single source of authoritative generally accepted accou nting principles (GAAP) and created a new Topic 105, font style="DISPLAY: inline; FONT-STYLE: italic"Generally Accepted Accounting Principles/font, in the General Principles and Objective Section of the Codification. Topic 105 is effective for interim and annual periods ending after September#160;15, 2009, and its adoption did not have an impact on our financial condition or results of operations./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"FASB ASC Topic 855, font style="DISPLAY: inline; FONT-STYLE: italic"#8220;Subsequent Events#8221;/font establishes general standards of accounting for disclosure of events that occur after the balance sheet date but before financial statements are issued or availabl e to be issued. It requires the disclosure of the date through which an entity has evaluated subsequent events and whether that date represents the date the financial statements were issued or were available to be issued. The adoption of Topic 855 did not have a material impact on the Company#8217;s consolidated financial statements and disclosures./font/div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"In response to the current credit crisis, FASB updated three ASC Topics to address fair value measurement concerns as follows:/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div table cellpadding="0" cellspacing="0" id="list_0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" tr val ign="top" td align="right" style="WIDTH: 36pt" divfont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif"#183;#160;#160;/font/div /td td div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"FASB ASC Topic 820, font style="DISPLAY: inline; FONT-STYLE: italic"Fair Value Measurements and Disclosures/font, provides additional guidance on measuring the fair value of financial instruments when market activity has decreased and quoted prices may reflect distressed transactions;/font/div /td /tr/table /div div table cellpadding="0" cellspacing="0" id="list_1" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" tr valign="top" td align="right" style="WIDTH: 36pt" divfont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif"#183;#160;#160;/font/div /td td div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"FASB ASC Topic 320, font style="DISPLAY: inline; FONT-STYLE: italic"Investments #8211; Debt and Equity Securities,/font amends the other-than-temporary impairment guidance for debt securities; and/font/div /td /tr/table /div div table cellpadding="0" cellspacing="0" id="list_2" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-F AMILY: Times New Roman" tr valign="top" td align="right" style="WIDTH: 36pt" divfont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif"#183;#160;#160;/font/div /td td div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"FASB ASC Topic 825, font style="DISPLAY: inline; FONT-STYLE: italic"Financial Instruments/font, expands the fair value disclosures required for financial instruments to interim reporting periods for publicly traded companies, including disclosure of the significant assumptions used to estimate the fair value of those financial instruments./font/div /td /tr/table /div div style="DISPLAY: block; TEXT-INDENT: 0 pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"The adoption of the above mentioned amendments to the FASB ASC did not have a material impact on our financial condition, results of operations, and disclosures./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"In January#160;2009, the Securities and Exchange Commission issued Release No.#160;33-9002, font style="DISPLAY: inline; FONT-STYLE: italic"#8220;Interactive Data to Improve Financial Reporting.#8221;/font The final rule requires companies to provide their financial statements and financial sta tement schedules to the Securities and Exchange Commission in interactive data format using the eXtensible Business Reporting Language (#8220;XBRL#8221;). The rule was adopted by the Securities and Exchange Commission to improve the ability of financial statement users to access and analyze financial data. The Securities and Exchange Commission adopted a phase-in schedule indicating when registrants must furnish interactive data. Under this schedule, the Company will be required to submit filings with financial statement information using XBRL commencing with our June#160;30, 2011 quarterly report on Form 10-Q. We are furnishing financial information in XBRL format starting with this quarterly report on Form 10-Q. As an earlier XBRL adopter, the Company may choose to discontinue furnishing XBRL data in the future until the required compliance date of June 30, 2011./font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div /d iv

SUBSEQUENT EVENTS	9 Months Ended
SUBSEQUENT EVENTS	Sep. 30, 2009
Notes To Financial Statements [Abstract]
Subsequent Events	div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"NOTE 10: /fontSUBSEQUENT EVENTS/font/div div style="DISPLAY: block; TEXT-INDENT: 0pt"br //div div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"a name="keyword"As required by the Subsequent Events Topic of the FASB ASC, the Company evaluated all events or transactions that occurred after September#160;30, 2009 up through November#160;5, 2009, the date the Company issued these financial statements. During this period the Company did not have any m aterial recognizable subsequent events./a/font/div /div

Document Information	9 Months Ended
Document Information	Sep. 30, 2009
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2009

Entity Information - USD ($)	9 Months Ended
Entity Information - USD ($)	Sep. 30, 2009	Oct. 30, 2009	Jun. 30, 2009
Entity Information [Line Items]
Entity Registrant Name	MANNATECH INC
Entity Central Index Key	0001056358
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Public Float			$ 85,313,436
Entity Common Stock, Shares Outstanding		26,480,788